Date: Monday 12th December 2022 Time: 12:00-13:00 GMT Speakers: Rob Donnelly, Paul Terrill, Aimee Weston and Lara Wolfson.
Who is this event intended for? Statisticians at all levels. What is the benefit of attending? This session promises to be an enjoyable and interactive way to learn more about your career as a statistician. We cover questions such as "Who is most pushy when negotiating salaries?" to "Is it better to specialise or diversify your skills".
Registration
Registration for this webinar is free, and is open to Members of PSI only.
To register for this event, please click here.
Overview
This PSI Lunch & Learn series focuses on career-related topics through a panel discussion, hosted by Claire Brittain & Chetan Mistry.
Upcoming session: The upcoming event - "Pharma-ly Fortunes" - will involve playing along to a Family Fortunes style survey - it promises to be a fun but informative session where we hear from our experienced panel on wide ranging career-related topics. We may even debunk some popular myths!
Christmas is approaching and in order to inject (even more) fun into these sessions we have put together a Family Fortunes style Lunch & Learn where you can provide your thoughts on a wide range of career related topics (through polls) and hear from our experienced panel on what they've seen observed over time and which career/recruitment trends are changing.
Come join us - you might be surprised by what you hear!
Speaker details
Speaker
Biography
Robert Donnelly
Rob is currently Commercial Manager at Plus-Project where he provides strategic leadership in recruitment, business development and marketing.
Prior to this, he worked specifically within Biometrics recruitment in the City of London.
Rob is a bit of a humbug and makes a point of avoiding all Christmas-related music until at least the 20th December. He is also dismayed at Mince Pies being available from his local Sainsbury’s early in October.
Paul Terrill
Paul started his career working as a statistician in the agrochemical industry before becoming a statistical trainer for SAS. He moved into the pharmaceutical industry in 2005 and worked for several CROs before becoming an independent consultant in 2020. Paul primarily provides support to biotech and small pharmaceutical companies who lack in-house statistical expertise.
Paul is always happy to receive some lego as a Christmas present, and often does!
Aimee Weston
Aimee has an extensive background in sales and recruitment. She moved to Warman O’Brien in March 2020, to specialise in biometrics recruitment, which has always been an area of interest to her. She is currently a Principal Consultant, working purely with statisticians, offering market advice and opportunities within top pharma’s, biotech’s and CRO’s.
Aimee enjoys creating relationships with her clients and candidates, offering a friendly platform to come for all that is recruitment in the pharma world!
At Christmas, Aimee loves the social aspect of seeing friends and family and has been known in the past to join the ‘pram race’ in her hometown of Windlesham on Boxing Day!
Lara Wolfson
Lara J. Wolfson is Executive Director and Head, Health Technology Assessment (HTA) Statistics in the Biostatistics and Research Decision Sciences (BARDS) organization at MSD Switzerland. Lara holds a PhD in Statistics from Carnegie Mellon University in the US, and an undergraduate degree from Simon Fraser University in Canada. Lara has held academic appointments at University of Waterloo in Canada and Brigham Young University in the US, and has previously worked as a scientist covering health economics, epidemiology, and statistics at the World Health Organization, as well as in the pharmaceutical industry in outcomes research and Market Access at both the Janssen Pharmaceutical Companies of Johnson & Johnson in Belgium and the Merck Center for Observational Research and Real-World Evidence in the US. Lara has authored more than 70 peer-reviewed journal articles, and currently chairs the HTA European Special Interest Group of the PSI (a professional organization for Statisticians in the Pharmaceutical Industry).
Lara currently lives in the Greater Zurich Area with her husband, twin sons, and a cat named Hokey Pokey.
While at Uni, Lara managed a seasonal Christmas store, so she knows how to professionally light and decorate 8 feet trees!
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Webinar: Development of Gene Therapies: Strategic, Scientific, Regulatory and Access Considerations
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Statisticians in the Pharmaceutical Industry Executive Office: c/o MCI UK Ltd | Unit 24/22 South | Building 4000 | Langstone Park| Langstone Road | Havant | PO9 1SA | UK